Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hope Northrup

Showing results (101-110 of 157) with videos related to

Pageof 16
Sort By:
Orphanet Journal of Rare Diseases|May 29, 2026
Development of a face-validated conceptual model structure for economic evaluation in phenylketonuria, through expert elicitationAnia C Muntau, Rongrong Zhang, Anupam Chakrapani, et al.
Annals of Neurology|November 17, 2022
Tubers Affecting the Fusiform Face Area Are Associated with Autism DiagnosisAlexander L Cohen, Mallory R Kroeck, Juliana Wall, et al.
Journal of Child Neurology|May 16, 2024
Abnormality of Early White Matter Development in Tuberous Sclerosis Complex and Autism Spectrum Disorder: Longitudinal Analysis of Diffusion Tensor Imaging MeasuresSiddharth Srivastava, Fanghan Yang, Anna K Prohl, et al.
Molecular Genetics and Metabolism Reports|May 2, 2024
Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial programCary O Harding, Nicola Longo, Hope Northrup, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 9, 2019
The Connectivity Fingerprint of the Fusiform Gyrus Captures the Risk of Developing Autism in Infants with Tuberous Sclerosis ComplexBenoit Scherrer, Anna K Prohl, Maxime Taquet, et al.
Molecular Genetics and Metabolism|December 3, 2023
Best practice recommendations for the management of anxiety during the pegvaliase journeyKendra J Bjoraker, Caroline Eggerding, Elisheva Ellenberg, et al.
Molecular Genetics and Metabolism|April 15, 2018
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)Janet Thomas, Harvey Levy, Stephen Amato, et al.
Journal of Neurodevelopmental Disorders|December 17, 2019
Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorderAnna K Prohl, Benoit Scherrer, Xavier Tomas-Fernandez, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 22, 2008
Characteristics of a spina bifida population including North American Caucasian and Hispanic individualsKit Sing Au, Phong X Tran, Chester C Tsai, et al.
American Journal of Medical Genetics. Part A|December 21, 2022
Patterns of co-occurring birth defects in children with anotia and microtiaJeremy M Schraw, Renata H Benjamin, Charles J Shumate, et al.
Pageof 16

Showing results (101-110 of 157) with videos related to

Sort By:
Pageof 16
Orphanet Journal of Rare Diseases|May 29, 2026
Development of a face-validated conceptual model structure for economic evaluation in phenylketonuria, through expert elicitationAnia C Muntau, Rongrong Zhang, Anupam Chakrapani, et al.
Annals of Neurology|November 17, 2022
Tubers Affecting the Fusiform Face Area Are Associated with Autism DiagnosisAlexander L Cohen, Mallory R Kroeck, Juliana Wall, et al.
Journal of Child Neurology|May 16, 2024
Abnormality of Early White Matter Development in Tuberous Sclerosis Complex and Autism Spectrum Disorder: Longitudinal Analysis of Diffusion Tensor Imaging MeasuresSiddharth Srivastava, Fanghan Yang, Anna K Prohl, et al.
Molecular Genetics and Metabolism Reports|May 2, 2024
Pegvaliase for the treatment of phenylketonuria: Final results of a long-term phase 3 clinical trial programCary O Harding, Nicola Longo, Hope Northrup, et al.
Cerebral Cortex (New York, N.Y. : 1991)|December 9, 2019
The Connectivity Fingerprint of the Fusiform Gyrus Captures the Risk of Developing Autism in Infants with Tuberous Sclerosis ComplexBenoit Scherrer, Anna K Prohl, Maxime Taquet, et al.
Molecular Genetics and Metabolism|December 3, 2023
Best practice recommendations for the management of anxiety during the pegvaliase journeyKendra J Bjoraker, Caroline Eggerding, Elisheva Ellenberg, et al.
Molecular Genetics and Metabolism|April 15, 2018
Pegvaliase for the treatment of phenylketonuria: Results of a long-term phase 3 clinical trial program (PRISM)Janet Thomas, Harvey Levy, Stephen Amato, et al.
Journal of Neurodevelopmental Disorders|December 17, 2019
Early white matter development is abnormal in tuberous sclerosis complex patients who develop autism spectrum disorderAnna K Prohl, Benoit Scherrer, Xavier Tomas-Fernandez, et al.
Birth Defects Research. Part A, Clinical and Molecular Teratology|October 22, 2008
Characteristics of a spina bifida population including North American Caucasian and Hispanic individualsKit Sing Au, Phong X Tran, Chester C Tsai, et al.
American Journal of Medical Genetics. Part A|December 21, 2022
Patterns of co-occurring birth defects in children with anotia and microtiaJeremy M Schraw, Renata H Benjamin, Charles J Shumate, et al.
Pageof 16